Beyond the membrane - The role of new PD solutions in enhancing global biocompatibility

Kidney International, Supplement

Volumn 64, Issue 88, 2003, Pages

  Pecoits Filho, Roberto ^b   Stenvinkel, Peter ^b   Heimbürger, Olof ^b   Lindholm, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

Glucose degradation product; Peritoneal dialysis; pH

Indexed keywords

BICARBONATE; DIALYSIS FLUID; LACTIC ACID; BIOMATERIAL; BUFFER; GLUCOSE; LACTIC ACID DERIVATIVE;

ACID BASE BALANCE; EXCIPIENT COMPATIBILITY; GLUCOSE TRANSPORT; HUMAN; HYPERMETABOLISM; HYPEROSMOLALITY; HYPEROSMOLARITY; LACTATE BLOOD LEVEL; MEMBRANE PERMEABILITY; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHRONIC KIDNEY FAILURE; DRUG EFFECT; INFLAMMATION; METABOLISM;

BICARBONATES; BIOCOMPATIBLE MATERIALS; BUFFERS; DIALYSIS SOLUTIONS; GLUCOSE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LACTATES; NUTRITIONAL STATUS; PERITONEAL DIALYSIS;

EID: 0344442351     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. GURLAND HJ, DAVISON AM, BONOMINI V, et al: Definitions and terminology in biocompatibility. Nephrol Dial Transplant 9(Suppl 2):4-10, 1994
2. FERIANI M: Bicarbonate-buffered CAPD solutions: From clinical trials to clinical practice. Perit Dial Int 17(Suppl 2):S51-55, 1997
3. COLES GA, GOKAL R, OGG C, et al: A randomized controlled trial of a bicarbonate-and a bicarbonate/lactate-containing dialysis solution in CAPD [published erratum appears in Perit Dial Int 17(3):223. 1997]. Perit Dial Int 17:48-51, 1997
4. WIESLANDER AP, NORDIN MK, MARTINSON E, et al: Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 39:343-348, 1993
5. LIBEREK T, TOPLEY N, JORRES A, et al: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 65:260-265, 1993
6. DOUVDEVANI A, RAPOPORT J, KONFORTY A, et al: Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 6:207-213, 1995
7. STIGANT CE, BARGMAN JM: What's new in peritoneal dialysis: Biocompatibility and continuous flow peritoneal dialysis. Curr Opin Nephrol Hypertens 11:597-602, 2002
8. MARSHALL J, JENNINGS P, SCOTT A, et al: Glycaemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 64:1480-1486, 2003
9. CHUNG SH, STENVINKEL P, BERGSTROM J, et al: Biocompatibility of new peritoneal dialysis solutions: What can we hope to achieve? Perit Dial Int 20:S57-67, 2000
10. DAVIES SJ, BRYAN J, PHILLIPS L, et al: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11:498-506, 1996
11. WANG T, HEIMBURGER O, WANIEWSKI J, et al: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 13:1242-1249, 1998
12. ATES K, NERGIZOGLU G, KEVEN K, et al: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60:761-776, 2001
13. CHURCHILL DN, THORPE KE, NOLPH KD, et al: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9:1285-1292, 1998
14. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
15. PECOITS-FILHO R, BARANY P, LINDHOLM B, et al: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002
16. FUJIMORI A, NAITO H, MIYAZAKI T, et al: Elevation of interleukin 6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function [letter]. Nephron 74:471-472, 1996
17. PECOITS-FILHO R, ARAUJO MR, LINDHOLM B, et al: Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17:1480-1486, 2002
18. WIESLANDER AP, ANDREN AH, NILSSON-THORELL C, et al: Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 15:348-352, 1995
19. WIESLANDER AP: Cytotoxicity of peritoneal dialysis fluid - Is it related to glucose breakdown products? Nephrol Dial Transplant 11:958-959, 1996
20. DAWNAY AB, MILLAR DJ: Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int 17:52-58, 1997
21. NAKAYAMA M, KAWAGUCHI Y, YAMADA K, et al: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186, 1997
22. HENLE T: A food chemist's view of advanced glycation end-products. Perit Dial Int 21(Suppl 3):S125-S130, 2001
23. ZEIER M, SCHWENGER V, DEPPISCH R, et al: Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 63:298-305, 2003
24. BRADY JP, HASBARGEN JA: A review of the effects of correction of acidosis on nutrition in dialysis patients. Semin Dial 13:252-255, 2000
25. VEROVE C, MAISONNEUVE N, EL AZOUZI A, et al: Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr 12:224-228, 2002
26. MCSHERRY E, MORRIS RC, JR.: Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 61:509-527, 1978
27. STEIN A, MOORHOUSE J, ILES-SMITH H, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52:1089-1095, 1997
28. PICKERING WP, PRICE SR, BIRCHER G, et al: Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 61:1286-1292, 2002
29. FERIANI M, RONCO C, LA GRECA G: Acid-base balance with different CAPD solutions. Perit Dial Int 16:S126-129, 1996
30. FERIANI M, KIRCHGESSNER J, LA GRECA G, et al: Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 54:1731-1738, 1998
31. FERIANI M, CAROBI C, LA GRECA G, et al: Clinical experience with a 39 mmol/L bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 17:17-21, 1997
32. SCHAMBYE HT, PEDERSEN FB, WANG P: Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: A cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 8:42-46, 1992
33. MACKENZIE RK, JONES S, MOSELEY A, et al: In vivo exposure to bicarbonate/lactate-and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function. Am J Kidney Dis 35:112-121, 2000
34. PLUM J, RAZEGHI P, LORDNEJAD RM, et al: Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells. Am J Kidney Dis 38:867-875, 2001
35. TAUER A, ZHANG X, SCHAUB TP, et al: Formation of advanced glycation end products during CAPD. Am J Kidney Dis 41:S57-S60, 2003
36. COLES GA, O'DONOGHUE DJ, PRITCHARD N, et al: A controlled trial of two bicarbonate-containing dialysis fluids for CAPD - Final report. Nephrol Dial Transplant 13:3165-3171, 1998
37. OTTE K, DENYS N, DIEPERINK H, et al: Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int 23:138-145, 2003
38. MACTIER RA, SPROSEN TS, GOKAL R, et al: Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 53:1061-1067, 1998
39. TRANAEUS A: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - Clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 20:516-523, 2000
40. PECOITS-FILHO R, MUJAIS S, LINDHOLM B: Future of icodextrin as an osmotic agent in peritoneal dialysis. Kidney Int 62(Suppl 81):S80-87, 2002
41. PANIAGUA R, AMATO D, VONESH E, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
42. BALASKAS EV, RODELA H, OREOPOULOS DG: Effects of intraperitoneal infusion of dextrose and amino acids on the appetite of rabbits. Perit Dial Int 13(Suppl 2):S490-498, 1993
43. ZHENG ZH, SEDERHOLM F, ANDERSTAM B, et al: Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats. Kidney Int 60:2392-2398, 2001
44. MAMOUN AH, ANDERSTAM B, SODERSTEN P, et al: Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats. Kidney Int 49:1276-1282, 1996
45. STENVINKEL P: Leptin and its clinical implications in chronic renal failure. Miner Electrolyte Metab 25:298-302, 1999
46. TETA D, BEVINGTON A, BROWN J, et al: Effects of acidosis on leptin secretion from 3T3-L1 adipocytes and on serum leptin in the uraemic rat. Clin Sci (Lond) 97:363-368, 1999
47. ZHENG F, QIU X, YIN S, et al: Changes in serum leptin levels in chronic renal failure patients with metabolic acidosis. J Ren Nutr 11:207-211, 2001
48. CARRASCO AM, RUBIO MA, SANCHEZ TOMMERO JA, et al: Acidosis correction with a new 25 mmol/l bicarbonate/15 mmol/l lactate peritoneal dialysis solution. Perit Dial Int 21:546-553, 2001
49. RIPPE B, SIMONSEN O, WIESLANDER A, et al: Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 17:27-34, 1997
50. SUNDARAM S, CENDOROGLO M, COOKER LA, et al: Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Am J Kidney Dis 30:680-689, 1997
51. DAVIES SJ, WOODROW G, DONOVAN K, et al: Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol 14:2338-2344, 2003